Intensive Treatment for Intermediate-Risk Relapse of Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies

ID Number 80-0066-00067

Principal Investigator(s)
Birte Wistinghausen

Department(s) or Division(s)
Hematology and Oncology

Description

The purpose of this study is:

1) To find out the effectiveness and side effects of the high dose combination chemotherapy treatment for all subjects on this study (A “subject” is a person taking part in the study.)

2) To find out the effectiveness and side effects of higher dose vincristine compared to standard dose vincristine.

You/your child may qualify for participation in this study because you/your child have been treated in the past for a cancer of the blood cells called acute lymphoblastic leukemia (ALL).

Contact Information
Katrina Watson
(212) 241-6906


Recruiting Patients: Yes